Grifols GRFS
NASDAQ GRFS
$8.62 -0.14 (-1.60%)
As of: Nov 11, 2026 · 10:06 AM EST

Grifols (GRFS) Notes Payables (2013 - 2015)

Updated

Grifols' Short-Term Borrowings was -$73.78 million in the quarter ended Dec 31, 2015, compared with -$66.64 million a year earlier.

Analysis

Grifols (GRFS) Notes Payables (2013 - 2015) Analysis & Trends

  • In earlier years, Short-Term Borrowings was -$66.64 million in the year ended Dec 31, 2014 and -$62.44 million in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Grifols 5.96 Bn 5.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -73.78 Mn
Dec 31, 2014 -66.64 Mn
Dec 31, 2013 -62.44 Mn
API Access

Grifols Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GRFS&period=max&api_key=YOUR_API_KEY